EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hypoxic lung adenocarcinoma‐derived exosomal miR ‐1290 induces M2 macrophage polarization by targeting SOCS3

Jiahui Gu, Shengrui Yang, Xueying Wang iD, Yining Wu, Jia Wei, Jian Xu iD

Cancer Medicine · 2023-06 · 12 (11) · 12639-12652

DOI: 10.1002/cam4.5954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 20.04.2023. Verfasst von Jiahui Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: MicroRNAs, Adenocarcinoma of Lung, Exosomes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Exosomes are critical mediators of tumor cell‐microenvironment cross talk. However, the mechanisms by which hypoxic Lung adenocarcinoma (LUAD)‐derived exosomes modulate macrophage polarization remain largely unknown. The aim of this study was to investigate the effects of hypoxic LUAD‐derived exosome on macrophage polarization and explore the underlying molecular mechanism. Materials and methods LUAD‐derived exosomes were isolated, and then confirmed by transmission electron microscopy, nanoparticle tracking analysis, and Western blot. Internalization of exosomes in macrophages was detected by confocal microscope. Gain‐ and loss‐of‐function experiments, rescue experiments, and xenograft models were performed to uncover the underlying mechanisms of exosomal miR‐1290 induced macrophage polarization in vitro and in vivo. Results miR‐1290 was enriched in hypoxic LUAD cancer cell‐derived exosomes and could be transferred to macrophages. Overexpression of miR‐1290 in macrophages‐induced polarization of M2 phenotype. Luciferase assay verified SOCS3 was the target of miR‐1290. Hypoxic LUAD cell‐derived exosomal miR‐1290 activated the STAT3 signaling pathway by targeting SOCS3 to promote M2 macrophage polarization.

Conclusion

Hypoxic LUAD cells generate miR‐1290‐rich exosomes that promote M2 polarization of macrophages. Targeting exosomal miR‐1290 may provide a potential immunotherapeutic strategy for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAdenocarcinoma of LungExosomesHumansCell Line, TumorMacrophagesSignal TransductionSuppressor of Cytokine Signaling ProteinsTumor MicroenvironmentSuppressor of Cytokine Signaling 3 Protein

Stichwörter der Autor:innen

exosomehypoxialung adenocarcinomamacrophage polarizationmiR-1290

Substanzen

MicroRNAsSuppressor of Cytokine Signaling ProteinsSOCS3 protein, humanSuppressor of Cytokine Signaling 3 ProteinMIRN1290 microRNA, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Branch of National Clinical Research Center for Laboratory Medicine, Nanjing, China.

ORCID-Profile: Xueying Wang, Jian Xu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Gu, J., Yang, S., Wang, X., Wu, Y., Wei, J., & Xu, J. (2023). Hypoxic lung adenocarcinoma‐derived exosomal miR ‐1290 induces M2 macrophage polarization by targeting SOCS3. Cancer Medicine, 12(11), 12639-12652. https://doi.org/10.1002/cam4.5954

Vancouver

Gu J, Yang S, Wang X, Wu Y, Wei J, Xu J. Hypoxic lung adenocarcinoma‐derived exosomal miR ‐1290 induces M2 macrophage polarization by targeting SOCS3. Cancer Medicine. 2023;12(11):12639-12652. doi:10.1002/cam4.5954

BibTeX
@article{Gu2023,
  author = {Gu, Jiahui and Yang, Shengrui and Wang, Xueying and Wu, Yining and Wei, Jia and Xu, Jian},
  title = {Hypoxic lung adenocarcinoma‐derived exosomal miR ‐1290 induces M2 macrophage polarization by targeting SOCS3},
  journal = {Cancer Medicine},
  year = {2023},
  volume = {12},
  number = {11},
  pages = {12639--12652},
  doi = {10.1002/cam4.5954}
}
Kostenlos starten →